Doximity, Inc. (NYSE: DOCS) is a Healthcare company in the Medical - Healthcare Information Services industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
Latest market price
25.77
-1.62-5.91%
News
Down 5.9% — Doximity Q1 Earnings Call Highlights (marketbeat.com).
Medium confidence
TA
Loading chart...
Snapshot
| Index | - | P/E | 30.79 | EPS (ttm) | 0.89 | Insider Own | 32.31% | Shs Outstand | 187.03M | Perf Week | 31.04% |
| Market Cap | 5.12B | Forward P/E | 17.19 | EPS next Y | 1.59 | Insider Trans | -0.04% | Shs Float | 181.35M | Perf Month | 24.49% |
| Enterprise Value | 4.86B | PEG | - | EPS next Q | - | Inst Own | - | Short Float | 11.43% | Perf Quarter | 5.26% |
| Income | 171.16M | P/S | 7.82 | EPS this Y | 44.79% | Inst Trans | - | Short Ratio | 5.08 | Perf Half Y | -17.77% |
| Sales | 655.57M | P/B | 5.46 | EPS next Y | 11.19% | ROA | 15.41% | Short Interest | 20.73M | Perf YTD | -38.12% |
| Book/sh | - | P/C | 16.33 | EPS next 5Y | 10.02% | ROE | 16.95% | 52W High | 71.96 -64.19% | Perf Year | -52.86% |
| Cash/sh | - | P/FCF | 17.12 | EPS past 3/5Y | 22.74% 52.20% | ROIC | 15.31% | 52W Low | 16.13 59.77% | Perf 3Y | -19.44% |
| Dividend Est. | - | EV/EBITDA | 19.94 | Sales past 3/5Y | 15.46% 25.52% | Gross Margin | 88.07% | Volatility | 16.61% 6.83% | Perf 5Y | -55.74% |
| Dividend TTM | - | EV/Sales | 7.41 | EPS Y/Y TTM | -10.81% | Oper. Margin | 29.60% | ATR (14) | 2.31 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 6.08 | Sales Y/Y TTM | 13.16% | Profit Margin | 25.48% | RSI (14) | 74.13 | Recom | 2.61 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.08 | EPS Q/Q | -42.22% | SMA20 | 26.35% | Beta | 1.25 | Target Price | 28.27 |
| Payout | 0.00% | Debt/Eq | 0.01 | Sales Q/Q | 5.07% | SMA50 | 28.75% | Rel Volume | 12.08 | Prev Close | 27.39 |
| Employees | 880 | LT Debt/Eq | 0.01 | Earnings | Nov 05 | SMA200 | -15.37% | Avg Volume | 5.39M | Price | 25.77 |
| IPO Date | Jun 24, 2021 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -8.21% 0.93% | Net Debt/EBITDA | -1.08 | Volume | 65,172,000 | Change | -5.91% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-07-26 | Reiterated | Needham | Buy | $27 → $41 |
| Aug-07-26 | Reiterated | Evercore ISI | In Line | $22 → $40 |
| Aug-07-26 | Reiterated | BMO Capital | Market Perform | $20 → $30 |
| Aug-07-26 | Reiterated | Canaccord Genuity | Buy | $30 → $36 |
| Jun-29-26 | Downgrade | B of A Securities | Buy → Underperform | |
| May-15-26 | Downgrade | Barclays | Overweight → Equal Weight | $20 |
| May-14-26 | Reiterated | Robert W. Baird | $18 | |
| May-14-26 | Reiterated | Morgan Stanley | Overweight | $49 → $35 |
| May-14-26 | Reiterated | Canaccord Genuity | Buy | $34 → $30 |
| May-14-26 | Downgrade | Wells Fargo | Overweight → Equal Weight | $32 → $18 |
Latest News
Aug-08-26
Aug-07-26
12:42PM
Sell Doximity Into The Major Rally Following Its Q1 Resultsseekingalpha.com
11:56AM
Here's Why Doximity Stock Is Flying Todayinvestopedia.com
11:36AM
10:32AM
'LinkedIn for Doctors' Stock Nearly Doubles After Earningsschaeffersresearch.com
09:18AM
09:15AM
06:18AM
12:54AM
Doximity, Inc. (DOCS) Q1 2027 Earnings Call Transcriptseekingalpha.com
Aug-06-26
Aug-06-2607:31PM
06:21PM
05:32PM
04:01PM
Doximity Announces Fiscal 2027 First Quarter Financial Resultsbusinesswire.com
Company
Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2026 3/31/2026 | FY 2025 3/31/2025 | FY 2024 3/31/2024 | FY 2023 3/31/2023 | FY 2022 3/31/2022 | FY 2021 3/31/2021 | FY 2020 3/31/2020 | FY 2019 3/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 656 | 645 | 570 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 78 | 70 | 56 | — | — | — | — | — | — | |
| Gross Profit | 577 | 575 | 515 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 241 | 229 | 191 | — | — | — | — | — | — | |
| Research and Development | 142 | 131 | 93 | — | — | — | — | — | — | |
| Other Operating Expense | -1 | 0 | 3 | — | — | — | — | — | — | |
| Operating Income | 195 | 215 | 228 | — | — | — | — | — | — | |
| Interest Expense | 0 | 0 | 0 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 32 | 35 | 36 | — | — | — | — | — | — | |
| Net Income Before Taxes | 226 | 250 | 264 | — | — | — | — | — | — | |
| Income Taxes | 59 | 54 | 40 | — | — | — | — | — | — | |
| Consolidated Net Income | 167 | 196 | 223 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 167 | 196 | 223 | — | — | — | — | — | — | |
| Net Income | 167 | 196 | 223 | — | — | — | — | — | — | |
| EPS (Recurring) | 0.89 | 1.05 | 1.19 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.89 | 1.05 | 1.19 | — | — | — | — | — | — | |
| EPS (Diluted) | 0.85 | 0.98 | 1.11 | — | — | — | — | — | — | |
| EBITDA | 244 | 264 | 241 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 30.32 | 23.78 | 52.28 | — | — | — | — | — | — | |
| Price To Sales Ratio | 7.19 | 6.76 | 19.04 | — | — | — | — | — | — | |
| Gross Margin | 87.96 | 89.15 | 90.35 | — | — | — | — | — | — | |
| Operating Margin | 29.73 | 33.33 | 40.00 | — | — | — | — | — | — | |
| Net Margin | 25.46 | 30.39 | 39.12 | — | — | — | — | — | — | |
| Shares Outstanding | 183 | 187 | 187 | — | — | — | — | — | — | |
| Market Capitalization | 4,716 | 4,357 | 10,852 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Sitaram Siddharth | Chief Accounting Officer | Jul 15 '26 | Option Exercise | 0.00 | 4,800 | 0 | 4,800 | Jul 20 |
| Sitaram Siddharth | Chief Accounting Officer | Jul 15 '26 | Sale | 22.02 | 1,732 | 38,139 | 93,774 | Jul 20 |
| Sitaram Siddharth | Interim PAO | Jun 08 '26 | Sale | 20.41 | 2,444 | 49,882 | 90,706 | Jun 10 |
| Sitaram Siddharth | Interim PAO | Jun 08 '26 | Option Exercise | 0.00 | 5,000 | 0 | 5,000 | Jun 10 |
| Sitaram Siddharth | Interim PFO and PAO | May 11 '26 | Sale | 25.77 | 2,309 | 59,503 | 89,396 | May 13 |
| Sitaram Siddharth | Interim PFO and PAO | May 11 '26 | Option Exercise | 0.00 | 5,000 | 0 | 5,000 | May 13 |
| Wampler Kira Scherer | Director | May 07 '26 | Sale | 26.06 | 9,000 | 234,540 | 19,839 | May 08 |
| Wampler Kira Scherer | Director | May 07 '26 | Option Exercise | 0.00 | 9,000 | 0 | 9,000 | May 08 |
| Sitaram Siddharth | Interim PFO and PAO | Apr 10 '26 | Sale | 21.09 | 2,427 | 51,185 | 86,705 | Apr 14 |
| Sitaram Siddharth | Interim PFO and PAO | Apr 10 '26 | Option Exercise | 0.00 | 5,000 | 0 | 5,000 | Apr 14 |
| Sitaram Siddharth | Interim PFO and PAO | Mar 10 '26 | Sale | 25.37 | 2,319 | 58,833 | 84,132 | Mar 12 |
| Sitaram Siddharth | Interim PFO and PAO | Mar 10 '26 | Option Exercise | 0.00 | 5,000 | 0 | 5,000 | Mar 12 |
| Sitaram Siddharth | Interim PFO and PAO | Feb 10 '26 | Sale | 27.88 | 2,282 | 63,622 | 81,451 | Mar 12 |
| Sitaram Siddharth | Interim PFO and PAO | Feb 10 '26 | Option Exercise | 0.00 | 5,000 | 0 | 5,000 | Mar 12 |
| Wampler Kira Scherer | Director | Mar 03 '26 | Sale | 26.00 | 2,000 | 52,000 | 19,839 | Mar 05 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.